Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel
Bill of Health
APRIL 26, 2022
Asked what the most pressing issues are in setting a national psychedelic policy agenda, Clark said that, while she desires expanded research into and access to psychedelic substances such as MDMA, she worries about their potential “pharmaceuticalization.”. “I I’m concerned about that,” she said.
Let's personalize your content